NOT:FRA
Novartis AG
133,96 €
arrow_downward
−0,77%(−1,04) 1 p
19. okt, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOT põhistatistika genereerimine…
Ava
135,00 €
Kõrge
135,00 €
Madal
133,96 €
Turu kapit.
307,12 mld
Keskm. maht
1,23 tuh
Maht
2,12 tuh
52 näd kõrgeim
144,08 €
52 näd madalaim
105,36 €
Töötajate arv
75 tuh
Ava
135,00 €
Kõrge
135,00 €
Madal
133,96 €
Turu kapit.
307,12 mld
Keskm. maht
1,23 tuh
Maht
2,12 tuh
52 näd kõrgeim
144,08 €
52 näd madalaim
105,36 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
marketscreener.com
·
12 tunni eest
Switzerland's Blue-chip Index Kicks Off Week Downbeat; Novartis Shares Decline
Yahoo Finance
·
15 tunni eest
Novartis Has Five Fast-Growing Drugs, but Is Its Valuation Asking Too Much?
ad-hoc-news.de
·
20 tunni eest
Novartis ends Fabhalta trial while Novartis stock trades at EUR 134.82
Investing.com
·
20 tunni eest
Novartis ends Fabhalta trial for lupus kidney disease
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com